Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer.

Carobene A, Guerra E, Locatelli M, Cucchiara V, Briganti A, Aarsand AK, Coşkun A, Díaz-Garzón J, Fernandez-Calle P, Røraas T, Sandberg S, Jonker N, Ceriotti F; European Federation of Clinical Chemistry; Laboratory Medicine Working Group on Biological Variation.

Clin Chim Acta. 2018 Nov;486:185-191. doi: 10.1016/j.cca.2018.07.043. Epub 2018 Jul 29.

PMID:
30063887
2.

Impact of multiparametric MRI and MRI-targeted biopsy on pre-therapeutic risk assessment in prostate cancer patients candidate for radical prostatectomy.

Dell'Oglio P, Stabile A, Dias BH, Gandaglia G, Mazzone E, Fossati N, Cucchiara V, Zaffuto E, Mirone V, Suardi N, Mottrie A, Montorsi F, Briganti A.

World J Urol. 2018 Jun 9. doi: 10.1007/s00345-018-2360-1. [Epub ahead of print]

PMID:
29948044
3.

Intra versus Inter Cross-resistance Determines Treatment Sequence between Taxane and AR-Targeting Therapies in Advanced Prostate Cancer.

Lombard AP, Liu L, Cucchiara V, Liu C, Armstrong CM, Zhao R, Yang JC, Lou W, Evans CP, Gao AC.

Mol Cancer Ther. 2018 Oct;17(10):2197-2205. doi: 10.1158/1535-7163.MCT-17-1269. Epub 2018 Jun 11.

4.

Will Image-guided Metastasis-directed Therapy Change the Treatment Paradigm of Oligorecurrent Prostate Cancer?

Giannarini G, Fossati N, Gandaglia G, Cucchiara V, Ficarra V, Mirone V, Montorsi F, Briganti A.

Eur Urol. 2018 Aug;74(2):131-133. doi: 10.1016/j.eururo.2018.03.021. Epub 2018 Apr 4.

PMID:
29625757
5.

Genomic Markers in Prostate Cancer Decision Making.

Cucchiara V, Cooperberg MR, Dall'Era M, Lin DW, Montorsi F, Schalken JA, Evans CP.

Eur Urol. 2018 Apr;73(4):572-582. doi: 10.1016/j.eururo.2017.10.036. Epub 2017 Nov 10. Review.

PMID:
29129398
6.

Human Prostate Tissue-derived Extracellular Matrix as a Model of Prostate Microenvironment.

Cazzaniga W, Nebuloni M, Longhi E, Locatelli I, Allevi R, Lucianò R, Senatore G, Ventimiglia E, Cucchiara V, Genovese L, Montorsi F, Alfano M, Salonia A, Cavarretta I.

Eur Urol Focus. 2016 Oct;2(4):400-408. doi: 10.1016/j.euf.2016.02.016. Epub 2016 Mar 10.

PMID:
28723472
7.

ABCB1 Mediates Cabazitaxel-Docetaxel Cross-Resistance in Advanced Prostate Cancer.

Lombard AP, Liu C, Armstrong CM, Cucchiara V, Gu X, Lou W, Evans CP, Gao AC.

Mol Cancer Ther. 2017 Oct;16(10):2257-2266. doi: 10.1158/1535-7163.MCT-17-0179. Epub 2017 Jul 11.

8.

Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer.

Liu C, Armstrong CM, Lou W, Lombard AP, Cucchiara V, Gu X, Yang JC, Nadiminty N, Pan CX, Evans CP, Gao AC.

Mol Cancer Ther. 2017 Aug;16(8):1521-1530. doi: 10.1158/1535-7163.MCT-16-0912. Epub 2017 May 12.

9.

Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.

Cucchiara V, Yang JC, Mirone V, Gao AC, Rosenfeld MG, Evans CP.

Cancers (Basel). 2017 Jan 16;9(1). pii: E9. doi: 10.3390/cancers9010009. Review.

10.

The impact of previous prostate surgery on the outcomes of laparoscopic radical prostatectomy.

Verze P, Greco F, Scuzzarella S, Bottone F, Palmieri A, Cucchiara V, Arcaniolo D, Imperatore V, Creta M, Mirone V.

Minerva Urol Nefrol. 2017 Feb;69(1):76-84. doi: 10.23736/S0393-2249.16.02612-6. Epub 2016 Jun 29.

PMID:
28009148
11.

Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: Can surgery be postponed safely?

Fossati N, Rossi MS, Cucchiara V, Gandaglia G, Dell'Oglio P, Moschini M, Suardi N, Dehò F, Montorsi F, Schiavina R, Mottrie A, Briganti A.

Urol Oncol. 2017 Apr;35(4):150.e9-150.e15. doi: 10.1016/j.urolonc.2016.11.010. Epub 2016 Dec 13.

PMID:
27986374
12.

The role of prostatic inflammation in the development and progression of benign and malignant diseases.

Gandaglia G, Zaffuto E, Fossati N, Cucchiara V, Mirone V, Montorsi F, Briganti A.

Curr Opin Urol. 2017 Mar;27(2):99-106. doi: 10.1097/MOU.0000000000000369. Review.

PMID:
27906778
13.

Pelvic lymph node dissection in prostate cancer: indications, extent and tailored approaches.

Bianchi L, Gandaglia G, Fossati N, Suardi N, Moschini M, Cucchiara V, Bianchi M, Damiano R, Schiavina R, Shariat SF, Montorsi F, Briganti A.

Urologia. 2017 Feb 3;84(1):9-19. doi: 10.5301/uro.5000139. Epub 2015 Dec 16. Review.

PMID:
26689534
14.

The New Prostate Cancer Grading System Does Not Improve Prediction of Clinical Recurrence After Radical Prostatectomy: Results of a Large, Two-Center Validation Study.

Dell'Oglio P, Karnes RJ, Gandaglia G, Fossati N, Stabile A, Moschini M, Cucchiara V, Zaffuto E, Karakiewicz PI, Suardi N, Montorsi F, Briganti A.

Prostate. 2017 Feb;77(3):263-273. doi: 10.1002/pros.23265. Epub 2016 Oct 18.

PMID:
27753114
15.

Early Postoperative Radiotherapy is Associated with Worse Functional Outcomes in Patients with Prostate Cancer.

Zaffuto E, Gandaglia G, Fossati N, Dell'Oglio P, Moschini M, Cucchiara V, Suardi N, Mirone V, Bandini M, Shariat SF, Karakiewicz PI, Montorsi F, Briganti A.

J Urol. 2017 Mar;197(3 Pt 1):669-675. doi: 10.1016/j.juro.2016.09.079. Epub 2016 Sep 23.

PMID:
27670915
16.

Effect of Stage Migration on Bladder Cancer: A Slow but Steady Improvement in Long-Term Survival Rates After Radical Cystectomy in Previous 25 Years.

Moschini M, Luzzago S, Cazzaniga W, Cucchiara V, Bandini M, Damiano R, Soria F, Klatte T, Shariat SF, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A.

Clin Genitourin Cancer. 2017 Apr;15(2):e223-e228. doi: 10.1016/j.clgc.2016.07.024. Epub 2016 Aug 8.

PMID:
27589904
17.

Incidence and Predictors of 30-Day Readmission After Robot-Assisted Radical Prostatectomy.

Moschini M, Gandaglia G, Fossati N, Dell'Oglio P, Cucchiara V, Luzzago S, Zaffuto E, Suardi N, Damiano R, Shariat SF, Montorsi F, Briganti A.

Clin Genitourin Cancer. 2017 Feb;15(1):67-71. doi: 10.1016/j.clgc.2016.06.002. Epub 2016 Jun 29.

PMID:
27452733
18.

Rationale for local treatment in the management of metastatic prostate cancer.

Gandaglia G, Fossati N, Dell'Oglio P, Moschini M, Cucchiara V, Suardi N, Mottrie A, Mirone V, Montorsi F, Briganti A.

Curr Opin Support Palliat Care. 2016 Sep;10(3):266-72. doi: 10.1097/SPC.0000000000000218. Review.

PMID:
27328411
19.

Perioperative and renal functional outcomes of laparoscopic partial nephrectomy (LPN) for renal tumours of high surgical complexity: a single-institute comparison between clampless and clamped procedures.

Verze P, Fedelini P, Chiancone F, Cucchiara V, La Rocca R, Fedelini M, Meccariello C, Palmieri A, Mirone V.

World J Urol. 2017 Mar;35(3):403-409. doi: 10.1007/s00345-016-1882-7. Epub 2016 Jun 20.

PMID:
27324881
20.

The Impact of Perioperative Blood Transfusion on Survival of Bladder Cancer Patients Submitted to Radical Cystectomy: Role of Anemia Status.

Moschini M, Bianchi M, Gandaglia G, Cucchiara V, Luzzago S, Pellucchi F, Damiano R, Serretta V, Briganti A, Montorsi F, Salonia A, Colombo R.

Eur Urol Focus. 2016 Apr;2(1):86-91. doi: 10.1016/j.euf.2015.03.002. Epub 2015 Jun 3.

PMID:
28723456
21.

Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience.

Moschini M, Karnes RJ, Sharma V, Gandaglia G, Fossati N, Dell'Oglio P, Cucchiara V, Capogrosso P, Shariat SF, Damiano R, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R.

Eur J Surg Oncol. 2016 May;42(5):735-43. doi: 10.1016/j.ejso.2016.02.011. Epub 2016 Feb 18.

PMID:
26927300
22.

Penile rehabilitation after radical prostatectomy: does it work?

Gandaglia G, Suardi N, Cucchiara V, Bianchi M, Shariat SF, Roupret M, Salonia A, Montorsi F, Briganti A.

Transl Androl Urol. 2015 Apr;4(2):110-23. doi: 10.3978/j.issn.2223-4683.2015.02.01. Review.

23.

Comparison of Treatment Emergent Adverse Events in Men With Premature Ejaculation Treated With Dapoxetine and Alternate Oral Treatments: Results From a Large Multinational Observational Trial.

Verze P, Cai T, Magno C, Sabella F, Cucchiara V, Palmieri A, Mirone V.

J Sex Med. 2016 Feb;13(2):194-9. doi: 10.1016/j.jsxm.2015.12.017. Epub 2016 Jan 21.

PMID:
26805941
24.

Incidence and Predictors of 30-Day Readmission in Patients Treated With Radical Cystectomy: A Single Center European Experience.

Moschini M, Gandaglia G, Dell'Oglio P, Fossati N, Cucchiara V, Burgio G, Mattei A, Damiano R, Shariat SF, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A.

Clin Genitourin Cancer. 2016 Aug;14(4):e341-6. doi: 10.1016/j.clgc.2015.12.017. Epub 2015 Dec 23.

PMID:
26797584
25.

Determinants of long-term survival of patients with locally advanced prostate cancer: the role of extensive pelvic lymph node dissection.

Moschini M, Fossati N, Abdollah F, Gandaglia G, Cucchiara V, Dell'Oglio P, Luzzago S, Shariat SF, Dehò F, Salonia A, Montorsi F, Briganti A.

Prostate Cancer Prostatic Dis. 2016 Mar;19(1):63-7. doi: 10.1038/pcan.2015.51. Epub 2015 Nov 10.

PMID:
26553644
26.

Effect of Allogeneic Intraoperative Blood Transfusion on Survival in Patients Treated With Radical Cystectomy for Nonmetastatic Bladder Cancer: Results From a Single High-Volume Institution.

Moschini M, Dell' Oglio P, Capogrosso P, Cucchiara V, Luzzago S, Gandaglia G, Zattoni F, Briganti A, Damiano R, Montorsi F, Salonia A, Colombo R.

Clin Genitourin Cancer. 2015 Dec;13(6):562-7. doi: 10.1016/j.clgc.2015.04.009. Epub 2015 May 4.

PMID:
26004301
27.

Patterns of Clinical Recurrence of Node-positive Prostate Cancer and Impact on Long-term Survival.

Nini A, Gandaglia G, Fossati N, Suardi N, Cucchiara V, Dell'Oglio P, Cazzaniga W, Luzzago S, Montorsi F, Briganti A.

Eur Urol. 2015 Nov;68(5):777-84. doi: 10.1016/j.eururo.2015.04.035. Epub 2015 May 8.

PMID:
25959166
28.

Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy.

Moschini M, Sharma V, Dell'oglio P, Cucchiara V, Gandaglia G, Cantiello F, Zattoni F, Pellucchi F, Briganti A, Damiano R, Montorsi F, Salonia A, Colombo R.

BJU Int. 2016 Apr;117(4):604-10. doi: 10.1111/bju.13146. Epub 2015 Jun 3.

29.

Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer.

Moschini M, Gandaglia G, Suardi N, Fossati N, Cucchiara V, Damiano R, Cantiello F, Shariat SF, Montorsi F, Briganti A.

Int J Urol. 2015 Jun;22(6):555-61. doi: 10.1111/iju.12748. Epub 2015 Mar 17.

30.

A Detailed Analysis of the Association Between Postoperative Phosphodiesterase Type 5 Inhibitor Use and the Risk of Biochemical Recurrence After Radical Prostatectomy.

Gallina A, Bianchi M, Gandaglia G, Cucchiara V, Suardi N, Montorsi F, Briganti A.

Eur Urol. 2015 Nov;68(5):750-3. doi: 10.1016/j.eururo.2015.02.002. Epub 2015 Feb 17.

PMID:
25700565
31.

How to optimize patient selection for robot-assisted radical prostatectomy: functional outcome analyses from a tertiary referral center.

Gandaglia G, Suardi N, Gallina A, Zaffuto E, Cucchiara V, Vizziello D, Shariat S, Cantiello F, Damiano R, Guazzoni G, Montorsi F, Briganti A.

J Endourol. 2014 Jul;28(7):792-800. doi: 10.1089/end.2014.0007. Epub 2014 Mar 24.

PMID:
24660774
32.

Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.

Suardi N, Gandaglia G, Gallina A, Di Trapani E, Scattoni V, Vizziello D, Cucchiara V, Bertini R, Colombo R, Picchio M, Giovacchini G, Montorsi F, Briganti A.

Eur Urol. 2015 Feb;67(2):299-309. doi: 10.1016/j.eururo.2014.02.011. Epub 2014 Feb 18.

PMID:
24571959
33.

External validation of the European association of urology recommendations for pelvic lymph node dissection in patients treated with robot-assisted radical prostatectomy.

Dell'Oglio P, Abdollah F, Suardi N, Gallina A, Cucchiara V, Vizziello D, Zaffuto E, Cantiello F, Damiano R, Shariat S, Montorsi F, Briganti A.

J Endourol. 2014 Apr;28(4):416-23. doi: 10.1089/end.2013.0571. Epub 2014 Jan 9.

PMID:
24188052
34.

Breast augmentation: Part III--preoperative considerations and planning.

Berry MG, Cucchiara V, Davies DM.

J Plast Reconstr Aesthet Surg. 2011 Nov;64(11):1401-9. doi: 10.1016/j.bjps.2011.03.028. Epub 2011 Apr 27. Review.

PMID:
21524951
35.

Breast augmentation: Part II--Adverse capsular contracture.

Berry MG, Cucchiara V, Davies DM.

J Plast Reconstr Aesthet Surg. 2010 Dec;63(12):2098-107. doi: 10.1016/j.bjps.2010.04.011. Epub 2010 Jun 25. Review.

PMID:
20579948
36.

A rare case of giant cutaneous horn.

Tillo O, Chin KF, Vidya R, Cucchiara V, Sterne GD.

Acta Chir Plast. 2010;52(2-4):57-9.

PMID:
21749012
37.

The intrinsic neuroadipofascial pedicled fasciocutaneous flap.

Ross GL, Cucchiara V, Oudit D, Berry MG, Howcroft A.

Br J Plast Surg. 2005 Jun;58(4):577-9. No abstract available.

PMID:
15897048
38.

An idea for umbilicus reconstruction.

Abenavoli FM, Cusano V, Cucchiara V, D'Amico C, Corvelli L.

Ann Plast Surg. 2001 Feb;46(2):194. No abstract available.

PMID:
11216626
39.

Controversial issues in diagnosis of liposarcomas of the thigh. A report of 18 cases.

Ribuffo D, Onesti MG, Elia E, Cucchiara V, Valeriani M, Scuderi N.

Scand J Plast Reconstr Surg Hand Surg. 1998 Sep;32(3):323-30.

PMID:
9785438

Supplemental Content

Loading ...
Support Center